Tilray Brands (TLRY) Accounts Payables (2017 - 2026)
Tilray Brands (TLRY) posted Accounts Payables of $224.0 million for Q1 2026, up 95.64% on a QoQ basis from $114.5 million in Q4 2025, and up 3.43% year-over-year from $216.6 million in Q1 2025.
Tilray Brands (TLRY) Accounts Payables (2017 - 2026) Analysis & Trends
Tilray Brands' Accounts Payables history runs 10 years deep, the most recent figure standing at $224.0 million for Q1 2026.
- Quarterly Accounts Payables rose 3.43% year-over-year to $224.0 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $224.0 million (up 3.43% YoY) and the FY2025 annual result came in at $235.3 million, down 2.74% from the prior year.
- Accounts Payables was $224.0 million for Q1 2026 at Tilray Brands, up from $114.5 million in the prior quarter.
- Across five years, Accounts Payables topped out at $242.0 million in Q2 2024 and bottomed at $68.6 million in Q2 2022.
- A 5-year average of $158.1 million and a median of $163.4 million in 2023 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables plunged 67.76% — and 2024, when it soared 199.03%.
- Tilray Brands' Accounts Payables stood at $75.7 million in 2022, then advanced by 16.69% to $88.4 million in 2023, then climbed by 12.12% to $99.1 million in 2024, then rose by 15.56% to $114.5 million in 2025, then soared by 95.64% to $224.0 million in 2026.
- Business Quant data shows TLRY's Accounts Payables at $224.0 million in Q1 2026, $114.5 million in Q4 2025, and $230.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 224.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 224.00 Mn |
| Nov 30, 2025 | 114.50 Mn |
| Aug 31, 2025 | 230.91 Mn |
| May 31, 2025 | 235.32 Mn |
| Feb 28, 2025 | 216.57 Mn |
| Nov 30, 2024 | 99.08 Mn |
| Aug 31, 2024 | 236.15 Mn |
| May 31, 2024 | 241.96 Mn |
| Feb 29, 2024 | 209.76 Mn |
| Nov 30, 2023 | 88.36 Mn |
| Aug 31, 2023 | 78.97 Mn |
| May 31, 2023 | 190.68 Mn |
| Feb 28, 2023 | 163.42 Mn |
| Nov 30, 2022 | 75.73 Mn |
| Aug 31, 2022 | 75.84 Mn |
| May 31, 2022 | 68.60 Mn |
| Feb 28, 2022 | 137.09 Mn |
| Nov 30, 2021 | 168.30 Mn |
| Aug 31, 2021 | 190.21 Mn |
| May 31, 2021 | 212.81 Mn |